Table 2.
Clinical characteristics | Relative diff. in mean admission HR | 95% CI | P | Relative diff. in mean daily HR change | 95% CI | P |
---|---|---|---|---|---|---|
Medical history | ||||||
Current/previous smoker | 0.202 | -3.33 to 3.73 | .911 | 0.001 | -0.183 to 0.185 | .990 |
Hypertension | -3.18 | -7.05 to 0.690 | .107 | 0.190 | 0.002 to 0.378 | .048 |
T2DM† | 1.21 | -2.31 to 4.72 | .500 | 0.220 | 0.044 to 0.395 | .014 |
Prior MI | 2.67 | -3.65 to 8.98 | .409 | 0.184 | -0.109 to 0.477 | .219 |
Prior CABG‡ | 8.98 | 1.59 to 16.37 | .017 | 0.255 | -0.043 to 0.552 | .093 |
Stroke | 1.10 | -7.28 to 9.47 | .797 | 0.229 | -0.127 to 0.585 | .207 |
Hyperlipidemia | 0.125 | -3.64 to 3.89 | .948 | 0.179 | 0.002 to 0.355 | .047 |
Depression | 12.5 | 4.29 to 20.6 | .003 | 0.319 | -0.155 to 0.793 | .187 |
Admission characteristics | ||||||
Diagnosis of STEMI | 0.984 | -2.77 to 4.73 | .607 | -0.067 | -0.251 to 0.118 | .479 |
LVEF <40% | 2.89 | -2.62 to 8.39 | .304 | 0.039 | -0.201 to 0.279 | .753 |
CABG performed | 2.41 | -2.31 to 7.13 | .317 | 0.049 | -0.198 to 0.296 | .697 |
PCI performed | -2.04 | -6.69 to 2.62 | .391 | -0.066 | -0.294 to 0.163 | .573 |
Transfusion performed | -0.026 | -5.76 to 5.71 | .993 | 0.068 | -0.182 to 0.317 | .595 |
Incomplete revascularization | 0.408 | -6.37 to 7.19 | .906 | -0.025 | -0.334 to 0.284 | .875 |
Development of heart failure | 2.50 | -3.47 to 8.47 | .412 | 0.287 | -0.002 to 0.576 | .052 |
Non-BB/CCB medications | ||||||
ACE inhibitors/ARBs | -0.551 | -4.74 to 3.64 | .797 | -0.007 | -0.194 to 0.180 | .942 |
Anticoagulants | 9.64 | 4.11 to 15.16 | .001 | -0.253 | -0.517 to 0.010 | .059 |
Diuretics | 5.61 | 1.60 to 9.61 | .006 | 0.096 | -0.109 to 0.302 | .358 |
ADP receptor inhibitors | 2.06 | -4.17 to 8.29 | .517 | -0.234 | -0.590 to 0.123 | .198 |
BB = beta-blocker; CCB = calcium channel blocker; other abbreviations as in Table 1.
After adjusting for CABG in T2DM association analysis.
After adjusting for T2DM in CABG association analysis.